FDA data Registry peer set 1 peer

Alternatives to safinamide

1 same-class SPL records vs safinamide - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

View safinamide → All alternatives

Brand: Xadago

MAO-B Inhibitor Prescription 1 alternative found

About safinamide

Safinamide (Xadago) is a drug used with levodopa/carbidopa to treat Parkinson's disease. It helps reduce "off" episodes, where symptoms like stiffness and slowness return.

Used for: Safinamide is used to treat Parkinson's disease. It is for people who take levodopa/carbidopa but still have "off" times. During these times, Parkinson's symptoms like stiffness and slow movement come back.

View full safinamide profile →

1 MAO-B Inhibitor peers (wide set)

rasagiline

Rx

Azilect

Rasagiline is used to treat Parkinson's disease. Parkinson's disease is a brain disorder that affects movement. This medicine can be used alone or with other Parkinson's medicines to help control your symptoms.

Compare safinamide vs rasagiline side-by-side →

safinamide vs rasagiline · FAERS reaction fields

FAERS top-reaction field "Fall" shows the widest count spread between safinamide and rasagiline in this extract (189-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect safinamide rasagiline
Fall 154 343
Hallucination 142 326
Dyskinesia 137 276
Gait Disturbance 93 145
Death 90 200
Parkinson^S Disease 89 216
Tremor 81 204
Fatigue 76 138

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

safinamide peer mix vs class inventory

Peer mix

0 OTC and 1 Rx SPL records in this peer set (1 total). Class inventory for MAO-B Inhibitor: 2 drugs.

Frequently Asked Questions

What same-class SPL records sit beside safinamide? ▼
This registry lists 1 MAO-B Inhibitor medication records beside safinamide, including rasagiline. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide MAO-B Inhibitor peer set (1 records)

safinamide (Xadago) sits in a wide MAO-B Inhibitor peer set (1 of 1 class peers shown). Labeled indication field for safinamide: Safinamide is used to treat Parkinson's disease.

Top FAERS reaction fields for safinamide total 1,008 reports across 10 reactions, set beside rasagiline. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full safinamide profile →

Field note for safinamide: see also the generic vs brand label guide when reading Xadago SPL strings.

Read our methodology - how this data is sourced, computed, and verified.